Mereo BioPharma Reports Clinical & Interim Biomarker Analysis at ESMO 2022
12 Sep 2022 //
GLOBENEWSWIRE
Mereo BioPharma To Present Data for PIb/II Study of Etigilimab + Nivolumab
02 Jun 2022 //
GLOBENEWSWIRE
Mereo BioPharma to Present Updated Data From PI/II Study of Etigilimab
26 May 2022 //
GLOBENEWSWIRE
Mereo Announces FDA Clearance to Proceed into a Phase 1b/2 study for Etigilimab
19 Oct 2020 //
GLOBENEWSWIRE
Celgene says no to Mereo’s cancer drug etigilimab
27 Jun 2019 //
PMLIVE
Celgene says no to Mereo’s cancer drug etigilimab
22 Jun 2019 //
PM LIVE